TherapeuticsMD Inc (TherapeuticsMD Inc (TXMD)) is higher by Monday morning, with the stock climbing 30.53% in pre-market trading to 2.48.
TXMD's short-term technical score of 11 indicates that the stock has traded less bullishly over the last month than 89% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 103 out of 146 industries, the stock ranks higher than 21% of stocks.
TherapeuticsMD Inc has risen 42.86% over the past month, closing at $1.42 on January 11. During this period of time, the stock fell as low as $1.37 and as high as $1.98. TXMD has an average analyst recommendation of Strong Buy. The company has an average price target of $7.40.
TherapeuticsMD Inc has a Long-Term Technical rank of 13. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 87% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 36 by this metric, TXMD ranks better than 15% of stocks.
Important Dates for Investors in TXMD:
-TherapeuticsMD Inc is set to release earnings on 2/18/2021. During their last earnings release the company posted EPS of $-0.71. -We do not have a set dividend date for TherapeuticsMD Inc at this time. Click Here to get the full Stock Score Report on TherapeuticsMD Inc (TXMD) Stock.